About the Journal

Aims and Scope

The Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.

Editorial Policy

The primary means of submission is through mstracker.com. The authors should identify an Associate Editor with expertise in the scope of the manuscript. The Associate Editor will be responsible for identifying reviewers and, after receiving reviews, for making a recommendation on the acceptability of the manuscript for publication. All final decisions on acceptability will be made by the Editor-in-Chief. The Associate Editors will be listed in the article as the Handling Associate Editor. Corresponding authors of accepted articles may be invited to join JAD as Associate Editors. See Information for Authors for details.

The Journal of Alzheimer’s Disease is a member of the Neuroscience Peer Review Consortium. The Consortium is an alliance of neuroscience journals that have agreed to accept manuscript reviews from each other.

Impact Factor/H-Factor

JAD has an Impact Factor of 3.612 (Journal Citation Reports, 2013), an h-index of 56 (Web of Science), an h5-index of 59 (Google Scholar), and an h5-median of 78 (Google Scholar).

Abstracting/Indexing

  • Academic Source Complete
  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • CAB Health
  • Chemical Abstracts Service (CAS)
  • CSA Biological Sciences
  • CSA Illumina
  • CSA Illustrata Natural Sciences
  • CSA Neurosciences Abstracts
  • e-psyche database
  • EBSCO database
  • Embase
  • EMCare
  • Index Copernicus
  • Index Medicus
  • Journal Citation Reports/Science Edition
  • MEDLINE
  • Prous Science Integrity
  • PsycInfo
  • PubMed
  • PubsHub
  • Science Citation Index Expanded (SciSearch)
  • Scopus
  • Ulrich's Periodicals Directory

Audience

JAD's targeted audience is comprised of basic science researchers and clinicians in the areas of Alzheimer's disease and related disorders.

Our Cover


For the current cover (2004-present), JAD editors chose Casey Reas, an artist and educator exploring abstract kinetic systems through diverse digital media including software, animation, and digital prints (see more of his work at http://www.groupc.net). Casey's cover for JAD was generated from software written specifically for the journal. It generates thousands of flower-like images and from these many variations, Casey selected the cover image. The chosen form and color are a reference to the magnolia flower of Darryl Evan’s cover illustration (1999-2003) of Hippocrates, where the flying pieces of the Alzheimer's puzzle and steel magnolia symbolize the one out of the sixteen Americans who stand behind each Alzheimer's victim. And so with this motif, the two covers, past and present, link and illustrate the continuance in JAD's mission to deliver top-quality science.

The Publisher

IOS logo

Commencing its publishing activities in 1987, IOS Press serves the information needs of scientific and medical communities worldwide. IOS Press now (co-)publishes over 100 international journals and about 120 book titles each year on subjects ranging from computer sciences and mathematics to medicine and the natural sciences.

IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information. All journals are available electronically and an e-book platform was launched in 2005.

Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008.